CardioKinetix raises $14.5M for catheter-based heart treatment
CardioKinetix, a Redwood City, Calif. life sciences startup working on a heart-failure treatment that could potentially help over a million patients, has raised a third round of funding, according to VentureWire.
The company’s procedure uses a catheter to strengthen parts of the heart, and protect areas damaged following heart attacks. The device is designed to be an alternative to a risky surgery typically only used in high-risk patients.
Previous investors Cutlass Capital, JPMorgan Partners and U.S. Venture… Continue Reading